Neurelis, Inc. announced it raised $1.5 Million in an initial filing from an offering of $10 Million

Jul 16, 2015•almost 10 years ago

Amount Raised

$1.5 Million

Round Type

seed

CaliforniaBiotechnology

Company Information

Company

Neurelis, Inc.

Location

California, United States

About

Neurelis is a specialty pharmaceutical firm that licenses, develops, and commercializes product candidates for epilepsy and the CNS market.